These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6092732)

  • 1. Polyneuropathy following vincristine therapy in two patients with Charcot-Marie-Tooth syndrome.
    Hogan-Dann CM; Fellmeth WG; McGuire SA; Kiley VA
    JAMA; 1984 Nov 23-30; 252(20):2862-3. PubMed ID: 6092732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vincristine neurotoxicity in Charcot-Marie-Tooth syndrome.
    Griffiths JD; Stark RJ; Ding JC; Cooper IA
    Med J Aust; 1985 Sep; 143(7):305-6. PubMed ID: 4046919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute vincristine neurotoxicity in a non-Hodgkin's lymphoma patient with Charcot-Marie-Tooth disease].
    Uno S; Katayama K; Dobashi N; Hirano A; Ogihara A; Yamazaki H; Usui N; Kobayashi T; Inoue K; Kuraishi Y
    Rinsho Ketsueki; 1999 May; 40(5):414-9. PubMed ID: 10390891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vincristine neurotoxicity.
    Chauncey TR; Showel JL; Fox JH
    JAMA; 1985 Jul; 254(4):507. PubMed ID: 4009878
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
    Nishikawa T; Kawakami K; Kumamoto T; Tonooka S; Abe A; Hayasaka K; Okamoto Y; Kawano Y
    J Pediatr Hematol Oncol; 2008 Jul; 30(7):519-21. PubMed ID: 18797198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose vincristine-induced severe polyneuropathy in a Hodgkin lymphoma patient: a case report (vincristine-induced severe polyneuropathy).
    Cil T; Altintas A; Tamam Y; Battaloğlu E; Isikdogan A
    J Pediatr Hematol Oncol; 2009 Oct; 31(10):787-9. PubMed ID: 19770686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Charcot-Marie-Tooth disease disclosed by a treatment with vincristine in familial Hodgkin's disease].
    Geny C; Gaio JM; Mallaret M; Goy A; Reymond F; Pegourie B; Yulis J; Perret JE
    Ann Med Interne (Paris); 1990; 141(8):709-10. PubMed ID: 2091516
    [No Abstract]   [Full Text] [Related]  

  • 8. Vincristine neuropathy in type I and type II Charcot-Marie-Tooth disease (hereditary motor sensory neuropathy).
    Igarashi M; Thompson EI; Rivera GK
    Med Pediatr Oncol; 1995 Aug; 25(2):113-6. PubMed ID: 7603395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vincristine neuropathy: neurophysiological and genetic studies in a case of Wilms tumor.
    Schiavetti A; Frascarelli M; Uccini S; Novelli A
    Pediatr Blood Cancer; 2004 Oct; 43(5):606-9. PubMed ID: 15382281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy.
    Moudgil SS; Riggs JE
    Ann Pharmacother; 2000 Oct; 34(10):1136-8. PubMed ID: 11054980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vincristine induced peripheral neuropathy potentiated by voriconazole in a patient with previously undiagnosed CMT1X.
    Porter CC; Carver AE; Albano EA
    Pediatr Blood Cancer; 2009 Feb; 52(2):298-300. PubMed ID: 18837430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charcot-Marie-Tooth disease type I diagnosed in a 5-year-old boy after vincristine neurotoxicity, resulting in maternal diagnosis.
    Olek MJ; Bordeaux B; Leshner RT
    J Am Osteopath Assoc; 1999 Mar; 99(3):165-7. PubMed ID: 10217912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life-threatening vincristine neurotoxicity.
    Naumann R; Mohm J; Reuner U; Kroschinsky F; Rautenstrauss B; Ehninger G
    Br J Haematol; 2001 Nov; 115(2):323-5. PubMed ID: 11703329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful alternative treatment containing vindesine for acute lymphoblastic leukemia with Charcot-Marie-Tooth disease.
    Ichikawa M; Suzuki D; Inamoto J; Ohshima J; Cho Y; Saitoh S; Kaneda M; Iguchi A; Ariga T
    J Pediatr Hematol Oncol; 2012 Apr; 34(3):239-41. PubMed ID: 22246157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication-induced exacerbation of neuropathy in Charcot Marie Tooth disease.
    Weimer LH; Podwall D
    J Neurol Sci; 2006 Mar; 242(1-2):47-54. PubMed ID: 16386273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vincristine neurotoxicity in the presence of hereditary neuropathy.
    Trobaugh-Lotrario AD; Smith AA; Odom LF
    Med Pediatr Oncol; 2003 Jan; 40(1):39-43. PubMed ID: 12426685
    [No Abstract]   [Full Text] [Related]  

  • 17. Vincristine treatment triggering the expression of asymptomatic Charcot-Marie-Tooth disease.
    Neumann Y; Toren A; Rechavi G; Seifried B; Shoham NG; Mandel M; Kenet G; Sharon N; Sadeh M; Navon R
    Med Pediatr Oncol; 1996 Apr; 26(4):280-3. PubMed ID: 8600343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charcot-Marie-Tooth disease associated with "essential tremor": Report of 7 cases and a review of the literature.
    Salisachs P
    J Neurol Sci; 1976 May; 28(1):17-40. PubMed ID: 932772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leber's optic neuropathy and Charcot-Marie-Tooth disease. Report of a case.
    McCluskey DJ; O'Connor PS; Sheehy JT
    J Clin Neuroophthalmol; 1986 Jun; 6(2):76-81. PubMed ID: 2942573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Chauvenet AR; Shashi V; Selsky C; Morgan E; Kurtzberg J; Bell B;
    J Pediatr Hematol Oncol; 2003 Apr; 25(4):316-20. PubMed ID: 12679647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.